Inhibition of nitric oxide synthase decreases anesthetic requirements of intravenous anesthetics in Xenopus laevis

Anesthesiology

Volumn 87, Issue 6, 1997, Pages 1479-1485

  Tonner, Peter H ^a   Scholz, Jens ^b   Lamberz, Lars ^b   Schlamp, Nikolas ^b   Schulte Am Esch, Jochen ^b  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b NONE

Author keywords

Anesthetic requirements; Intravenous anesthetics: thiopental; propofol; ketamine; Nitric oxide synthase inhibition: L NAME

Indexed keywords

ANESTHETIC AGENT; KETAMINE; NITRIC OXIDE SYNTHASE; PROPOFOL; THIOPENTAL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; ENZYME INHIBITION; INTRAVENOUS ANESTHESIA; INTRAVENOUS DRUG ADMINISTRATION; MINIMUM LUNG ALVEOLUS CONCENTRATION; NEUROTRANSMITTER RELEASE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; STEADY STATE; XENOPUS LAEVIS;

ANESTHETICS, INTRAVENOUS; ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; KETAMINE; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; PROPOFOL; REFLEX; THIOPENTAL; XENOPUS LAEVIS;

EID: 0031454009     PISSN: 00033022     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000542-199712000-00027     Document Type: Article

References (47)

1. Dawson VL, Dawson TM: Nitric oxide actions in neurochemistry. Neurochem Int 1996; 29:97-110
2. Tobin JR, Martin LD, Breslow MJ, Traystman RJ: Selective anesthetic inhibition of brain nitric oxide synthase. ANESTHESIOLOGY 1994; 81:1264-9
3. Kant GJ, Muller TW, Lenox RH, Meyerhoff JL: In vivo effects of pentobarbital and halothane anesthesia on levels of adenosine 3′,5′-monophosphate and guanosine 3′,5′-monophosphate in rat brain regions and pituitary. Biochem Pharmacol 1980; 29:1891-6
4. Vulliemoz Y, Verosky M, Alpert M, Triner L: Effects of enflurane on cerebellar cGMP and on motor activity in the mouse. Br J Anaesth 1983; 55:79-84
5. Johns RA, Moscicki JC, DiFazio CA: Nitric oxide synthase inhibitor dose-dependently and reversibly reduces the threshold for halothane anesthesia. A role for nitric oxide in mediating consciousness? ANESTHESIOLOGY 1992; 77:779-84
6. Adachi T, Kurata J, Nakano S, Murakawa M, Shichino T, Shirakami G, Shinomura T, Mori K: Nitric oxide synthase inhibitor does not reduce minimum alveolar concentration of halothane in rats. Anesth Analg 1994; 78:1154-7
7. Adachi T, Shinomura T, Nakao S, Kurata J, Murakawa M, Shichino T, Seo N, Mori K: Chronic treatment with nitric oxide synthase (NOS) inhibitor profoundly reduces cerebellar NOS activity and cyclic guanosine monophosphate but does not modify minimum alveolar concentration. Anesth Analg 1995; 81:862-5
8. Ichinose F, Huang PL, Zapol WM: Effects of targeted neuronal nitric oxide synthase gene disruption and nitro-L-arginine methylester on the threshold for isoflurane anesthesia. ANESTHESIOLOGY 1995; 83:101-8
9. Galley HF, Webster NR: Brain nitric oxide synthase activity is decreased by intravenous anesthetics. Anesth Analg 1996; 83:591-4
10. Terasako K, Nakamura K, Miyawaki I, Toda H, Kakuyama M, Mori K: Inhibitory effects of anesthetics on cyclic guanosine monophosphate (cGMP) accumulation in rat cerebellar slices. Anesth Analg 1994; 79:921-6
11. Firestone S, Firestone LL, Ferguson C, Blanck D: Staurosporine, a protein kinase c inhibitor, decreases the general anesthetic requirement in rana pipiens tadpoles. Anesth Analg 1993; 77:1026-30
12. Tonner PH, Poppers DM, Miller KW: The general anesthetic potency of propofol and its dependence on hydrostatic pressure. ANESTHESIOLOGY 1992; 77:926-31
13. Tonner PH, ScholzJ, Koch C, Schulte am Esch J: The anesthetic effect of dexmedetomidine does not adhere to the Meyer-Overton rule but is reversible by hydrostatic pressure. Anesth Analg 1997; 84:618-23
14. Waud DR: On biological assays involving quantal responses. J Pharmacol Exp Ther 1972; 183:577-607
15. Lipnick R, DEJ, Gilforn I: Comparion of fish toxicity screening data for 55 alcohols with the quantitative structure-activity relationship predictions of minimum toxicity for nonreactive nonelectrolyte organic compounds. Environ Toxicol Chem 1985; 4:281-96
16. Alifimoff J, Firestone L, Miller K: Anaesthetic potencies of primary alkanols: Implications for the molecular dimensions of the anesthetic site. Br J Pharmacol 1989; 96:9-16
17. Firestone LL, Miller JC, Miller KW: Tables of Physical and Pharmacological Properties of Anesthetics. Edited by SH Roth, KW Miller. New York, Plenum, 1986, pp 455-70
18. Palmer R, Ashton D, Moncada S: Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature 1988; 333:664-6
19. Bredt DS, Glatt CE, Hwang PM, Fotuhi M, Dawson TM, Snyder SH: Nitric oxide synthase protein and mRNA are discretely localized in neuronal populations of the mammalian CNS together with NADPH diaphorase. Neuron 1991; 7:615-24
20. Garthwaite J: Glutamate, nitric oxide and cell-cell signaling in the nervous system. Trends Neurosci 1991; 14:60-7
21. Garthwaite J, Charles SL, Chess-Williams R: Endothelium-derived relaxing factor release on activation of NMDA receptors suggests role as intracellular messenger in brain. Nature 1988; 336:385-8
22. Garthwaite J, Southam E, Anderton M: A kainate receptor linked to nitric oxide synthesis from arginine. J Neurochem 1989; 53:952-4
23. Bredt D, Snyder S: Isolation of nitric oxide synthetase, a calmodulin-requiring enzyme. Proc Natl Acad Sci U S A 1990; 87:682-5
24. Moncada S: The 1991 Ulf von Euler lecture. Acta Physiol Scand 1992; 145:201-7
25. Radomski MW, Martin JF, Moncada S: Synthesis of nitric oxide by haemocytes of the American horseshoe crab. Phil Trans R Soc London 1991; 334:129-33
26. Crowe MJ, Brown TJ, Bresnahan JC, Beattie MS: Distribution of NADPH-diaphorase reactivity in the spinal cord of metamorphosing and adult Xenopus laevis. Brain Res Dev Brain Res 1995; 86:155-66
27. Dzoljic M, De Vries R: Nitric oxide synthase inhibition reduces wakefulness. Neuropharmacology 1994; 33:1505-9
28. Clark IA, Rockett KA, Cowden WB: Possible central role of nitric oxide in conditions clinically similar to cerebral malaria. Lancet 1992; 340:894-6
29. Schroeder RA, Kuo PC: Nitric oxide: Physiology and pharmacology. Anesth Analg 1995; 81:1052-9
30. Durieux ME: Muscarinic signaling in the central nervous system: recent developments and anesthetic implications. ANESTHESIOLOGY 1996; 84:173-89
31. Vulliemoz Y, Shen H, Virag L: Alpha-2 adrenoceptor agonists decrease cyclic guanosine 3′,5′-monophosphate in the mouse brain. ANESTHESIOLOGY 1996; 85:544-50
32. Muldoon S, Van Dyke R, Hart J: Nitric oxide and anesthetics. Curr Opin Anaesth 1994; 7:87-90
33. A receptor/chloride channel complex in anesthesia. ANESTHESIOLOGY 1993; 78:757-76
34. Valtschanoff JG, Weinberg RJ, Rustioni A, Schmidt HHHW: Colocalization of neuronal nitric oxide synthase with GABA in rate cuneate nucleus. J Neurocyt 1995; 24:237-45
35. Seilicovich A, Duvilanski BH, Pisera D, Theas S, Gimeno M, Rettori V, McCann SM: Nitric oxide inhibits hypothalamic luteinizing hormone-releasing hormone release by releasing gamma-aminobutyric acid. Proc Natl Acad Sci U S A 1995; 92:3421-4
36. Segovia G, Porras A, Mora F: Effects of a nitric oxide donor on glutamate and GABA release in striatum and hippocampus of the conscious rat. Neuroreport 1994; 5:1937-40
37. Morgan WW, Bermudez J, Chang X: The relative potency of pentobarbital in suppressing the kainic acid- or the N-methyl-D-aspartic acid-induced enhancement of cGMP in cerebellar cells. Eur J Pharmacol 1991; 204:335-8
38. Zucker J: Central cholinergic depression reduces MAC for isoflurane in rats. Anesth Analg 1991; 72:790-5
39. Mathes C, Thompson SH: The nitric oxide/cGMP pathway couples muscarinic receptors to the activation of Ca2+ influx. J Neurosci 1996; 16:1702-9
40. Moro V, Badaut J, Springhetti V, Edvinsson L, Seylaz J, Lasbennes F: Regional study of the co-localization of neuronal nitric oxide synthase with muscarinic receptors in the rat cerebral cortex. Neuroscience 1995; 69:797-805
41. Xu Z, Tong C, Eisenach JC: Acetylcholine stimulates the release of nitric oxide from rat spinal cord. ANESTHESIOLOGY 1996; 85:107-11
42. Iwamoto ET, Marion L: Pharmacologic evidence that spinal muscarinic analgesia is mediated by an L-arginine/nitric oxide/cyclic GMP cascade in rats. J Pharmacol Exp Ther 1994; 271:601-8
43. Johns R: Nitric oxide, cyclic guanosine monophosphate, and the anesthetic state. ANESTHESIOLOGY 1996; 85:457-9
44. Thomson A, West D, Lodge D: An N-methylaspartate receptor-mediated synapse in rat cerebral cortex: A site of action of ketamine? Nature 1985; 313:479-81
45. Irifune M, Shimizu T, Nomoto M, Fukuda T: Ketamine-induced anesthesia involves the N-methyl-D-aspartate receptor-channel complex in mice. Brain Res 1992; 596:1-6
46. Gonzales JM, Loeb AL, Reichard PS, Irvine S: Ketamine inhibits glutamate-, N-methyl-D-aspartate-, and quisqualate-stimulated cGMP production in cultured cerebral neurons. ANESTHESIOLOGY 1995; 82:205-13
47. Johns RA: Nitric oxide and minimum alveolar concentration. TKO or knockout? ANESTHESIOLOGY 1995; 83:6-7